Sankyo Company Limited

Download PDF
Email profile changes
Upgrade this profile
Add a new company

Members:
Ammend this profile
Login

Agriculture

Contact Details: 5-1Nihonbashi Hon-cho 3-chome Chuo-ku Tokyo Tokyo 103 Japan Tel: 81 3 5255 7111 Fax: 81 3 5255 7047 Email: WWW: www.sankyo.co.jp/

Recent Publications by Sankyo Company Limited:
Population pharmacokinetics of olmesartan following oral administration of its prodrug, olmesartan medoxomil: in healthy volunteers and hypertensive patients. BACKGROUND: Olmesartan medoxomil (CS-866) is a new orally active...	12th August, 2006	Clinical Pharmacology and Biostatistics Department, Sankyo Company Ltd,	Clin Pharmacokinet. 2005;44(12):1329-42.
Effect of combined treatment with an angiotensin II receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits. The purpose of this study was to examine whether coadministration of...	1st March, 2006	Pharmacology and Molecular Biology Research Laboratories, Sankyo Company,	J Cardiovasc Pharmacol. 2005 Oct;46(4):556-62.
Improvement of single nucleotide polymorphism genotyping by allele-specific PCR using primers modified with an ENA residue. When we placed an ENA residue into primers at the 3' end, or the n-1, n-2,...	10th September, 2005	Lead Discovery Research Laboratories, Sankyo Company Ltd., 2-58, Hiromachi	Anal Biochem. 2005 May 15;340(2):287-94. DOI Direct Link
Brain insulin impairs amyloid-beta(1-40) clearance from the brain. Cerebral amyloid-beta peptide (Abeta) clearance plays a key role in...	20th May, 2005	Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo	J Neurosci. 2004 Oct 27;24(43):9632-7. DOI Direct Link
Evaluation of the protein binding ratio of drugs by a micro-scale ultracentrifugation method. Ultracentrifugation methods have been widely used for the determination of...	13th November, 2004	Pharmacokinetics and Drug Delivery Research Laboratories, Sankyo Company,	J Pharm Sci. 2004 Apr;93(4):847-54. DOI Direct Link
→View more Sankyo Company Limited research publications.

BioNews Results for Sankyo Company Limited:
Johnson & Johnson CEO William Weldon: Leadership in a Decentralised Company	Leader.co.za:  Jun 28 2008 2:21PM Matching: sankyo company
Learn about the World Ophthalmic Pharmaceutical Drugs Market	Market Wire:  Jun 27 2008 9:48PM Matching: sankyo company
Learn about the World Ophthalmic Pharmaceutical Drugs Market	Street Insider:  Jun 27 2008 8:51PM Matching: sankyo company
US FDA extends review period for antiplatelet drug prasugrel	PharmaBiz:  Jun 26 2008 7:44AM Matching: sankyo company
Research and Markets: A Competitor Analysis of the Antihypertensives Market Including Detailed Market Informat	TradingMarkets:  Jun 25 2008 9:36AM Matching: sankyo company
Promote your company here: BioNewsCast - Press Release Distribution	→View more Sankyo Company Limited news.

Sankyo Company Limited Patents:
US Patent No.	Title
6670360	Optically active pyrrolopyridazine derivatives
6844173	Strain of Streptomyces griseus
6844363	Hydrates of a neuraminic acid compound and crystalline forms thereof
6878703	Pharmaceutical composition
6887893	Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
→View more Sankyo Company Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 427 times since April 2007, the link to the organisation's website has been followed 70 times

Recent Search Terms used to find this page: prasugrel patent | Daiichi Sankyo Population PK | prasugrel patents preparation | Prasugrel patents preparation | Drug Metabolism and Pharmacokinetics Research Laboratories, Sankyo Co., Ltd. | Prasugrel population PK | Prasugrel population PK | Prasugrel population PK | sankyo fax | protein binding ultracentrifugation Sankyo Company Ltd | .

Search for more companies in Tokyo

Search for more companies in Tokyo

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Sankyo Company Limited

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.